Cambridge, MA, US • 500 - 999 Employees
BioTech/Drugs
Blueprint Medicines develops kinase inhibitors for genomically defined cancer subsets of precision therapies, designed to allow patients to live longer and healthier lives.
Oncology drug discoveryOncologyGenomically defined diseasesRare diseasesTransformative drugsRobust drug pipelineSystemic mastocytosisHepatocellular carcinomaOrphan drugsSmall moleculesKinase inhibitorPersonalized medicineNovel cancer therapiesB2BBiotechSaaSCommercial Physical ResearchBiotechnologyBiotech Pharmaceuticals